Literature DB >> 26788212

Conus medullaris ganglioneuroma with syringomyelia radiologically mimicking ependymoma: A case report.

Kai Wang1, Jianping Dai2.   

Abstract

Ganglioneuromas are rare, benign, well-differentiated tumors of the conus medullaris. Approximately 20 cases of spinal cord ganglioneuroma, and only 1 case of mixed chemodectoma-ganglioneuroma of the conus medullaris have been previously reported. The present study presents the case of a 38-year-old man with a histopathological diagnosis of conus medullaris ganglioneuroma. The patient presented with hypoesthesia in the lower limbs, muscle atrophy of the right lower limb and dysuria. Magnetic resonance imaging analysis led to a diagnosis of ependymoma. Histopathological analysis of the excised mass revealed typical, well-differentiated ganglion cells, consistent with a ganglioneuroma. The mass was associated with a neighboring syringomyelia. At an 18 month follow-up the patient had recovered, although some remaining difficulty in walking and urinating remained. The aim of the present report was to raise awareness that when ganglioneuromas present in unusual locations, analogous radiological findings may mislead investigators to consider more common pathologies and thus result in misdiagnosis. The present case demonstrates the importance of considering the potential differential diagnoses for neural tissue neoplasms.

Entities:  

Keywords:  conus medullaris; ganglioneuroma; magnetic resonance imaging; syringomyelia

Year:  2015        PMID: 26788212      PMCID: PMC4665408          DOI: 10.3892/ol.2015.3815

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Russell and Rubinstein's pathology of tumors of the nervous system. Sixth edition

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 2.  Presacral ganglioneuromas. Report of five cases and review of the literature.

Authors:  Ashok Modha; Philip Paty; Mark H Bilsky
Journal:  J Neurosurg Spine       Date:  2005-03

3.  Paraganglioma of the sacral spinal canal.

Authors:  Mohamed Lmejjati; Fabrice Parker; Catherine Lacroix; Marc Tadié
Journal:  Neurosciences (Riyadh)       Date:  2011-07       Impact factor: 0.906

4.  Metabolic activity and clinical features of primary ganglioneuromas.

Authors:  B Geoerger; B Hero; D Harms; J Grebe; K Scheidhauer; F Berthold
Journal:  Cancer       Date:  2001-05-15       Impact factor: 6.860

5.  Adrenal ganglioneuromas: experience from a retrospective study in a Chinese population.

Authors:  Liping Li; Jialiang Shao; Jianjun Gu; Xiang Wang; Lianxi Qu
Journal:  Urol J       Date:  2014-05-06       Impact factor: 1.510

Review 6.  The pathogenesis of syringomyelia associated with lesions at the foramen magnum: a critical review of existing theories and proposal of a new hypothesis.

Authors:  David N Levine
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

Review 7.  Presacral ganglioneuroma: a case report and review of literature.

Authors:  Guido Cerullo; Daniele Marrelli; Bernardino Rampone; Clelia Miracco; Stefano Caruso; Marianna Di Martino; Maria Antonietta Mazzei; Franco Roviello
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

8.  Sacral ganglioneuroma in a 19-year-old woman.

Authors:  James Dimou; Jeremy H Russell; Rondhir Jithoo; Meron Pitcher
Journal:  J Clin Neurosci       Date:  2009-10-07       Impact factor: 1.961

Review 9.  Symmetric dumbbell ganglioneuromas of bilateral C2 and C3 roots with intradural extension associated with von Recklinghausen's disease: case report.

Authors:  Kazuhiko Kyoshima; Keiichi Sakai; Miki Kanaji; Susumu Oikawa; Sumio Kobayashi; Atsushi Sato; Jun Nakayama
Journal:  Surg Neurol       Date:  2004-05

10.  Unspecific clinical manifestation of cauda equina myxopapillary ependymoma.

Authors:  Gayrat Maratovich Kariev; Elbek Shodievich Halikulov; Shavkat Orzikuloviich Rasulov
Journal:  Asian J Neurosurg       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.